登录 | 注册    关注公众号  
微信公众号
搜索
 >  Cell>LAG-3 >SCJUR-STF065

Human LAG-3 (Luc) Jurkat Reporter Cell Development Service

For research use only.

描述(Description)

The Human LAG-3 (Luc) Jurkat Reporter Cell was engineered to not only express the NFAT response element driving luciferase expressing systems, but also express the receptor full length human LAG-3 (Gene ID: 3902), which can use to evaluate the potency of LAG-3 blockade. When co-cultured with target cells expressing human MHCⅡ, the LAG-3/MHCⅡ interaction inhibits TCR signaling and NFAT-mediated luminescence. Blocking the LAG-3/MHCⅡ interaction by anti-LAG-3 antibodies releases the inhibitory signals and results in TCR activation and NFAT-mediated luminescence.

应用说明(Application)

Screen for anti-human LAG-3 antibody.

LAG-3 Assay Principles

生长特性(Growth Properties)

Suspension

筛选标记(Selection Marker)

Puromycin (5 μg/mL) + Hygromycin (20 μg/mL)

培养基(Culture Medium)

RPMI-1640 + 10% FBS

冻存液(Freeze Medium)

Serum-free cell cryopreservation medium

装量(Quantity)

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

存储(Storage)

Frozen in liquid nitrogen.

支原体检测(Mycoplasma Testing)

Negative

无菌检测(Sterility Testing)

Negative

使用说明(Instructions for Use)

See data sheet for detailed culturing and assay protocol.

 

Receptor Assay

LAG-3 FACS

Expression analysis of human LAG-3 on Human LAG-3 (Luc) Jurkat Reporter Cell by FACS.
Human LAG-3 (Luc) Jurkat Reporter Cell or negative control cell were stained with PE-labeled anti-human LAG-3 antibody.

Protocol

 

Application

LAG-3 APPLICATION

Blocking activity of anti-human LAG-3 antibody.
This reporter cell was incubated with serial dilutions of antibodies in the presence of target cells expressing human MHCⅡ. The EC50 of anti-human LAG-3 antibody was approximately 0.11 μg/mL.

Protocol

 

Passage Stability

LAG-3 PASSAGE

Passage stability analysis by anti-human LAG-3 antibody stimulation.
The continuously growing Human LAG-3 (Luc) Jurkat Reporter Cell was stimulated with serial dilutions of antibodies in the presence of target cells expressing human MHCⅡ. Anti-human LAG-3 antibody stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 14-38.

Protocol

如有相关细胞池需求请联系我们

 

背景(Background)

Lymphocyte activation gene 3 protein (LAG3) is also known as CD antigen CD223 and protein FDC, which belongs to immunoglobulin (Ig) superfamily. As a CD4 homologue, LAG3 expressed on the surface of activated conventional T cells and regulatory T (Treg) cells. In conventional T cells, LAG-3 acts as an inhibitory receptor of T cell inflammation.

 

Permits & Restrictions

This cell line is provided for research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. You are not allowed to share, distribute, sell, modify, sublicense, or otherwise make this cell line available for use to other laboratories, departments, research institutions, hospitals, universities, or biotech companies. AcroBiosystems does not warrant the suitability of this cell line for any particular use, and does not accept any liability in connection with the handling or use of this cell line.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
LAG-3靶点信息
英文全称:Lymphocyte activation gene 3 protein
中文全称:淋巴细胞活化基因3蛋白
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:29详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定